試す - 無料

Banks rush to unwind repledged gold loans

Mint Chennai

|

November 13, 2025

The Reserve Bank of India’s (RBI) recent gold loannorms have plugged a loophole that allowed banks and non-bank financiers to lend against gold repledged by informal lenders, according to four bankers with knowledge of the matter.

- Subhana Shaikh & Anshika Kayastha

Banks rush to unwind repledged gold loans

The RBI has said gold repledging is not allowed, and that such loans cannot be renewed.

(Reuters)

The bankers said that these are loans given to pawn brokers against gold that these brokers have taken as collateral from their own customers in the first place. The RBI, the bankers said, has now said that repledging of gold is not allowed and, therefore, lenders that made such loans will not be able to renew them.

These bankers who spoke on the condition of anonymity said that the practice of lending against repledged gold was not confined to a single lender. However, they said that the size of this repledged gold and loans is difficult to ascertain, since most of it is to the unorganized sector.

In a revised June 2025 framework detailing norms for loans against gold jewellery, the RBI had barred regulated entities from lending against repledged gold.

“Alender shall not avail loans by re-pledging gold or silver pledged to it by its borrower, or extend loans to other lenders, entities or individuals by accepting gold or silver collateral pledged to such lenders, entities, or individuals by their borrowers as collateral,” said the RBI's gold loan norms.

Mint Chennai からのその他のストーリー

Mint Chennai

Mint Chennai

Lenskart wants artificial intelligence to test your eyes

It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

More companies to take a hit as labour codes debut

Reworked gratuity and leave encashments spell additional expenses for India Inc

time to read

2 mins

January 13, 2026

Mint Chennai

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Chennai

Trump’s investigation of Powell is also a warning to the next Fed chair

The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

States flag Almont-Kid syrup as tests find contaminants

Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol

time to read

1 mins

January 13, 2026

Mint Chennai

Mint Chennai

India at 100: Our choices today will define the next two decades

India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path

time to read

4 mins

January 13, 2026

Mint Chennai

Now, inheritance works without probate—but why it still matters

Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases

time to read

6 mins

January 13, 2026

Mint Chennai

Why VCs have a new deep-tech playbook

where fundraising starts to drag,\" said Chand.

time to read

1 min

January 13, 2026

Mint Chennai

TCS, HCLTech deliver Q3 revenue surprise

clearer.

time to read

2 mins

January 13, 2026

Mint Chennai

Mint Chennai

US productivity is rising and it risks warping monetary policy

America's neutral rate ought to be going up but will the Fed listen?

time to read

3 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size